Cargando…
PI3K Inhibition by BKM120 Results in Antiproliferative Effects on Corticotroph Tumor Cells
Purpose: Cushing’s disease is associated with significant morbidity, thus additional tumor-directed drugs with the potential to exert antineoplastic effects on corticotroph adenoma cells are desired. The PI3K (phosphoinositide-3-kinase)/AKT (protein kinase B) pathway, which plays regulatory roles in...
Autores principales: | Oliveira, Helen A, Bueno, Ana C, Pugliesi, Renata S, Silva-Júnior, Rui M P, de Castro, Margaret, Martins, Clarissa S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265828/ http://dx.doi.org/10.1210/jendso/bvab048.1116 |
Ejemplares similares
-
MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019) -
A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021) -
Clinical Correlation to E-cadherin and Granulation Patterns in Corticotroph Tumors
por: Lipe, Kristin A, et al.
Publicado: (2021) -
ODP312 Giant Silent Corticotroph Adenoma: Presentation of 3 Cases
por: Oliveira, Miriam C, et al.
Publicado: (2022) -
Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)